A3P Digitalization

Forum A3P Spain

A3P Digitalization

When?

November 18, 2025

Where?

Renaissance Barcelona Fira Hotel

Barcelona, Spain

Format?

Conferences, Partner Sessions, Round Table & Exhibition

Introduction

This A3P conference will bring together industry experts from the pharmaceutical sector to explore the challenges and opportunities of digitalization.
A full day dedicated to delving into the regulatory aspects of Annex 11, as well as in-depth sessions on alarm review, the digitalization of cell therapy, and warehouse automation.
In addition, we will host a round table to analyze synergies and emerging use cases.
This event offers a rigorous and practical approach, ideal for quality, production, and engineering teams seeking to understand and adopt innovative digital strategies.
Another intense day to share experiences, discuss solutions, and continue building together the pharmaceutical Industry 4.0.

Official conference language: Spanish 🇪🇸
Simultaneous translation: English 🇬🇧
ATTENDENT
EXHIBITION

PROGRAM

Related articles

Digitalization in cleaning validation an overview of possibilities, challenges, and opportunities for savings?

La Vague 83 / October 2024
Within the pharmaceutical industry, there has been a significant surge in articles and publications related to digitalization, with abundant references to concepts such as Pharma 4.0. This article intends to shine a spotlight on the ongoing discussions surrounding digitalization within the realms of cleaning validation, overall hygiene protocols, and adjacent quality assurance activities...
Button

What does 21 CFR Part 11 mean in everyday online analytics?

La Vague 83 / October 2024
The article highlights some details how FDA 21 CFR Part 11 and EU Annex 11 shall be implemented and can be “lived” effectively. By reaching compliance more easily, operational efficiency is enhanced, and costs are lowered. You (The customer) is given peace-of-mind. The article gives answers to some key questions like “Can I fulfill 21 CFR Part 11 easily?” and “How do I reach data integrity?”
Button

Key Allies in Preventing Contaminants and Impurities in Bioproduction

In the biopharmaceutical industry, the prevention of microbial contaminants and the control of process related impurities are critical requirements to ensure patient safety, therapeutic efficacy, and regulatory compliance. As processes become more complex and regulatory expectations intensify, Blow-Fill-Seal (BFS) and Single-Use Systems (SUS) technologies are emerging as key solutions to strengthen risk management. By minimizing potential entry points for contaminants and streamlining production flows, these innovations address the industry's demands for robustness, traceability, and responsiveness.
a3p.org